schliessen

Filtern

 

Bibliotheken

Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation

The aim of this study was to validate a criteria-specific long-term survival prediction model (MHCAT) in a large cohort of hepatocellular carcinoma (HCC) patients after liver transplantation (LT) in China. Independent risk factors in MHCAT were retrospectively analysed for HCC patients recorded in t... Full description

Journal Title: Scientific Reports (Nature Publisher Group) Jun 2015, Vol.5, p.11733
Main Author: Teng, Fei
Other Authors: Han, Qiu-Cheng , Ding, Guo-Shan , Ni, Zhi-Jia , Fu, Hong , Guo, Wen-Yuan , Shi, Xiao-Min , Gao, Xiao-Gang , Ma, Jun , Fu, Zhi-Ren
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 20452322 ; DOI: 10.1038/srep11733
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest1899560150
title: Validation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
format: Article
creator:
  • Teng, Fei
  • Han, Qiu-Cheng
  • Ding, Guo-Shan
  • Ni, Zhi-Jia
  • Fu, Hong
  • Guo, Wen-Yuan
  • Shi, Xiao-Min
  • Gao, Xiao-Gang
  • Ma, Jun
  • Fu, Zhi-Ren
subjects:
  • Transplants & Implants
  • Liver Cancer
  • Liver Transplantation
  • Immunology
  • Hepatocellular Carcinoma
ispartof: Scientific Reports (Nature Publisher Group), Jun 2015, Vol.5, p.11733
description: The aim of this study was to validate a criteria-specific long-term survival prediction model (MHCAT) in a large cohort of hepatocellular carcinoma (HCC) patients after liver transplantation (LT) in China. Independent risk factors in MHCAT were retrospectively analysed for HCC patients recorded in the China Liver Transplant Registry. Survival predictions for each patient were calculated using MHCAT scores and the Metroticket formula separately, and the prediction efficacy of MHCAT and Metroticket was compared using the area under ROC curve (c-statistic). A total of 1371 LTs for HCC were analysed in the study, with a median follow-up of 22.2 months (IQR 6.1-72.4 months). The proportions meeting the Milan, UCSF, Fudan and Hangzhou criteria were 34.4%, 39.7%, 44.2% and 51.9%, respectively. The c-statistics for MHCAT predictions of 3- and 5-year survival rates of HCC recipients were 0.712-0.727 and 0.726-0.741, respectively. Among these patients, 1298 LTs for HCC were ultimately selected for...
language: eng
source:
identifier: E-ISSN: 20452322 ; DOI: 10.1038/srep11733
fulltext: fulltext_linktorsrc
issn:
  • 20452322
  • 2045-2322
url: Link


@attributes
ID802479968
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid1899560150
sourceidproquest
recordidTN_proquest1899560150
sourcesystemPC
pqid1899560150
display
typearticle
titleValidation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
creatorTeng, Fei ; Han, Qiu-Cheng ; Ding, Guo-Shan ; Ni, Zhi-Jia ; Fu, Hong ; Guo, Wen-Yuan ; Shi, Xiao-Min ; Gao, Xiao-Gang ; Ma, Jun ; Fu, Zhi-Ren
ispartofScientific Reports (Nature Publisher Group), Jun 2015, Vol.5, p.11733
identifierE-ISSN: 20452322 ; DOI: 10.1038/srep11733
subjectTransplants & Implants ; Liver Cancer ; Liver Transplantation ; Immunology ; Hepatocellular Carcinoma
descriptionThe aim of this study was to validate a criteria-specific long-term survival prediction model (MHCAT) in a large cohort of hepatocellular carcinoma (HCC) patients after liver transplantation (LT) in China. Independent risk factors in MHCAT were retrospectively analysed for HCC patients recorded in the China Liver Transplant Registry. Survival predictions for each patient were calculated using MHCAT scores and the Metroticket formula separately, and the prediction efficacy of MHCAT and Metroticket was compared using the area under ROC curve (c-statistic). A total of 1371 LTs for HCC were analysed in the study, with a median follow-up of 22.2 months (IQR 6.1-72.4 months). The proportions meeting the Milan, UCSF, Fudan and Hangzhou criteria were 34.4%, 39.7%, 44.2% and 51.9%, respectively. The c-statistics for MHCAT predictions of 3- and 5-year survival rates of HCC recipients were 0.712-0.727 and 0.726-0.741, respectively. Among these patients, 1298 LTs for HCC were ultimately selected for...
languageeng
source
version5
oafree_for_read
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
linktorsrc$$Uhttp://search.proquest.com/docview/1899560150/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Teng, Fei
1Han, Qiu-Cheng
2Ding, Guo-Shan
3Ni, Zhi-Jia
4Fu, Hong
5Guo, Wen-Yuan
6Shi, Xiao-Min
7Gao, Xiao-Gang
8Ma, Jun
9Fu, Zhi-Ren
titleValidation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
descriptionThe aim of this study was to validate a criteria-specific long-term survival prediction model (MHCAT) in a large cohort of hepatocellular carcinoma (HCC) patients after liver transplantation (LT) in China. Independent risk factors in MHCAT were retrospectively analysed for HCC patients recorded in the China Liver Transplant Registry. Survival predictions for each patient were calculated using MHCAT scores and the Metroticket formula separately, and the prediction efficacy of MHCAT and Metroticket was compared using the area under ROC curve (c-statistic). A total of 1371 LTs for HCC were analysed in the study, with a median follow-up of 22.2 months (IQR 6.1-72.4 months). The proportions meeting the Milan, UCSF, Fudan and Hangzhou criteria were 34.4%, 39.7%, 44.2% and 51.9%, respectively. The c-statistics for MHCAT predictions of 3- and 5-year survival rates of HCC recipients were 0.712-0.727 and 0.726-0.741, respectively. Among these patients, 1298 LTs for HCC were ultimately selected for...
subject
0Transplants & Implants
1Liver Cancer
2Liver Transplantation
3Immunology
4Hepatocellular Carcinoma
general
0English
1Nature Publishing Group
210.1038/srep11733
3Medical Database
4ProQuest Science Journals
5Health & Medical Collection (Alumni edition)
6Medical Database (Alumni edition)
7Science Database (Alumni edition)
8Health & Medical Collection
9ProQuest Biology Journals
10Biological Science Database
11Publicly Available Content Database
12ProQuest Biological Science Collection
13ProQuest Central
14ProQuest Hospital Collection
15ProQuest Natural Science Collection
16Hospital Premium Collection (Alumni edition)
17ProQuest SciTech Collection
18ProQuest Health & Medical Complete
19ProQuest Medical Library
20Natural Science Collection
21ProQuest Central (new)
22ProQuest Central K-12
23ProQuest Central Korea
24SciTech Premium Collection
25Health Research Premium Collection
26Health Research Premium Collection (Alumni edition)
27ProQuest Central Essentials
28ProQuest One Academic
sourceidproquest
recordidproquest1899560150
issn
020452322
12045-2322
rsrctypearticle
creationdate2015
addtitleScientific Reports (Nature Publisher Group)
searchscope
01000084
11000273
21000283
31006761
41006762
51006765
61006772
71007067
81007108
91007856
101007945
111008886
121009127
131009240
1410000038
1510000039
1610000047
1710000050
1810000118
1910000119
2010000120
2110000155
2210000156
2310000157
2410000158
2510000164
2610000238
2710000253
2810000255
2910000256
3010000257
3110000258
3210000260
3310000268
3410000270
3510000271
3610000281
3710000302
3810000348
3910000360
40proquest
scope
01000084
11000273
21000283
31006761
41006762
51006765
61006772
71007067
81007108
91007856
101007945
111008886
121009127
131009240
1410000038
1510000039
1610000047
1710000050
1810000118
1910000119
2010000120
2110000155
2210000156
2310000157
2410000158
2510000164
2610000238
2710000253
2810000255
2910000256
3010000257
3110000258
3210000260
3310000268
3410000270
3510000271
3610000281
3710000302
3810000348
3910000360
40proquest
lsr43
01000084true
11000273true
21000283true
31006761true
41006762true
51006765true
61006772true
71007067true
81007108true
91007856true
101007945true
111008886true
121009127true
131009240true
1410000038true
1510000039true
1610000047true
1710000050true
1810000118true
1910000119true
2010000120true
2110000155true
2210000156true
2310000157true
2410000158true
2510000164true
2610000238true
2710000253true
2810000255true
2910000256true
3010000257true
3110000258true
3210000260true
3310000268true
3410000270true
3510000271true
3610000281true
3710000302true
3810000348true
3910000360true
startdate20150601
enddate20150601
citationpf 11733 vol 5
lsr30VSR-Enriched:[pqid, date, issue]
sort
titleValidation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
authorTeng, Fei ; Han, Qiu-Cheng ; Ding, Guo-Shan ; Ni, Zhi-Jia ; Fu, Hong ; Guo, Wen-Yuan ; Shi, Xiao-Min ; Gao, Xiao-Gang ; Ma, Jun ; Fu, Zhi-Ren
creationdate20150601
lso0120150601
facets
frbrgroupid5376778669087356631
frbrtype5
newrecords20170522
languageeng
creationdate2015
topic
0Transplants & Implants
1Liver Cancer
2Liver Transplantation
3Immunology
4Hepatocellular Carcinoma
collection
0Medical Database
1ProQuest Science Journals
2Health & Medical Collection (Alumni edition)
3Medical Database (Alumni edition)
4Science Database (Alumni edition)
5Health & Medical Collection
6ProQuest Biology Journals
7Biological Science Database
8Publicly Available Content Database
9ProQuest Biological Science Collection
10ProQuest Central
11ProQuest Hospital Collection
12ProQuest Natural Science Collection
13Hospital Premium Collection (Alumni edition)
14ProQuest SciTech Collection
15ProQuest Health & Medical Complete
16ProQuest Medical Library
17Natural Science Collection
18ProQuest Central (new)
19ProQuest Central K-12
20ProQuest Central Korea
21SciTech Premium Collection
22Health Research Premium Collection
23Health Research Premium Collection (Alumni edition)
24ProQuest Central Essentials
25ProQuest One Academic
prefilterarticles
rsrctypearticles
creatorcontrib
0Teng, Fei
1Han, Qiu-Cheng
2Ding, Guo-Shan
3Ni, Zhi-Jia
4Fu, Hong
5Guo, Wen-Yuan
6Shi, Xiao-Min
7Gao, Xiao-Gang
8Ma, Jun
9Fu, Zhi-Ren
jtitleScientific Reports (Nature Publisher Group)
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext_linktorsrc
addata
aulast
0Teng
1Han
2Ding
3Ni
4Fu
5Guo
6Shi
7Gao
8Ma
aufirst
0Fei
1Qiu-cheng
2Guo-shan
3Zhi-jia
4Hong
5Wen-yuan
6Xiao-min
7Xiao-gang
8Jun
9Zhi-ren
au
0Teng, Fei
1Han, Qiu-Cheng
2Ding, Guo-Shan
3Ni, Zhi-Jia
4Fu, Hong
5Guo, Wen-Yuan
6Shi, Xiao-Min
7Gao, Xiao-Gang
8Ma, Jun
9Fu, Zhi-Ren
atitleValidation of a criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
jtitleScientific Reports (Nature Publisher Group)
risdate20150601
volume5
spage11733
pages11733
eissn20452322
formatjournal
genrearticle
ristypeJOUR
abstractThe aim of this study was to validate a criteria-specific long-term survival prediction model (MHCAT) in a large cohort of hepatocellular carcinoma (HCC) patients after liver transplantation (LT) in China. Independent risk factors in MHCAT were retrospectively analysed for HCC patients recorded in the China Liver Transplant Registry. Survival predictions for each patient were calculated using MHCAT scores and the Metroticket formula separately, and the prediction efficacy of MHCAT and Metroticket was compared using the area under ROC curve (c-statistic). A total of 1371 LTs for HCC were analysed in the study, with a median follow-up of 22.2 months (IQR 6.1-72.4 months). The proportions meeting the Milan, UCSF, Fudan and Hangzhou criteria were 34.4%, 39.7%, 44.2% and 51.9%, respectively. The c-statistics for MHCAT predictions of 3- and 5-year survival rates of HCC recipients were 0.712-0.727 and 0.726-0.741, respectively. Among these patients, 1298 LTs for HCC were ultimately selected for...
copLondon
pubNature Publishing Group
doi10.1038/srep11733
urlhttp://search.proquest.com/docview/1899560150/
issue1
oafree_for_read
date2015-06-22